CD44 and neoplasm: Practically, the fluorescence density was negligible in tumor tissues as compared to that of liver, which indicates that nanophotosensitizers efficiently targeted the CD44 receptor of tumor cells and their delivery capacity can be controlled by CD44 recognition.